Lotty Hooft

Full Professor

Biography

Prof. Dr. Lotty Hooft is Professor of Evidence Synthesis and Knowledge Translation in Healthcare at the Julius Center, UMC Utrecht, and Director of Cochrane Netherlands. She heads the Department of Epidemiology and Health Economics and the international MSc in Epidemiology program. With more than two decades of experience, she is an internationally recognized expert in systematic reviews, diagnostic and prognostic test evaluation, and guideline development, and has helped shape key reporting and risk-of-bias standards including TRIPOD, STARD, and PROBAST, as well as the (de)implementation of evidence-based healthcare practices.

Contact

lhooft@umcutrecht.nl

Pure profile

Recent publications

All publications

PRISMA-Children and Adolescents (PRISMA-C) 2026 extension statement and explanation Ami Baba, Mufiza Farid-Kapadia, Maureen Smith, Lisa Hartling, David Moher, Lotty Hooft, Martin Offringa
BMJ (Clinical research ed.), 2026, vol. 393

Gaps and variation in evaluation criteria for digital health technologies T. Bazuin, M. P.T. Kusters, D. L. Idema, M. J. Van der Laan, R. Spijker, M. S. Oerbekke, P. Heus, L. Hooft, K. Jenniskens
Health Policy and Technology, 2026, vol. 15

The Inclusion and Intended Use of Prediction Models in Clinical Guidelines Emilie de Kanter, Robin W M Vernooij, Linde Huis In 't Veld, Ewoud Schuit, Karel G M Moons, Lotty Hooft, Johanna A A G Damen
Journal of Clinical Epidemiology, 2026, vol. 195

Antiarrhythmic drugs vs catheter ablation as rhythm control for atrial fibrillation Demy L Idema, Mike P T Kusters, Linde F Huis In 't Veld, Simone Huygens, Matthijs Versteegh, René Spijker, Lotty Hooft, Kevin Jenniskens, Johanna A A Damen
Heart Rhythm, 2026, vol. 23, p.1465-1475

Sick leave and engagement as workforce well-being proxies in hospital departments Tom Bazuin, Michiel S. Oerbekke, Saskia Bontjer, Iris M. Reijmerink, Dave A. Dongelmans, Arie Franx, J. K.Götz Wietasch, Lotty Hooft, Maarten J. van der Laan
BMJ Open, 2026, vol. 16

Agreement testing of AMSTAR-PF, a tool for quality appraisal of systematic reviews of prognostic factor studies Michael L Henry, Neil E O'Connell, Richard D Riley, Karel G M Moons, Beverley J Shea, Lotty Hooft, Sarah B Wallwork, Johanna A A G Damen, Nicole Skoetz, Ruth P Appiah, Carolyn Berryman, Sophie M Crouch, Grace A Ferencz, Ashley R Grant, Katherine M Henry, Aleksandra M Herman, Emma L Karran, Indika Koralegedera, Hayley B Leake, Erin MacIntyre, Brendan Mouatt, Karma Phuentsho, Daniel A Van Der Laan, Ellana Welsby, Louise K Wiles, Erica M Wilkinson, Marelle K Wilson, Monique V Wilson, G Lorimer Moseley
BMJ Open, 2026, vol. 16

External positions

Lid ZEGG evaluatiecommissie (Zorg Evaluatie en Gepast Gebruik) - Evaluatie van ZEGG aanvragen vanuit UMC perspectief - ZonMW/ZIN

Lid Wetenschappelijke Adviesraad (WAR) Care & Cure - Adviseren en beoordelen van duidingsrapporten - Zorginstituut Nederland

Lid van onafhankelijke adviescommissie - Toetsen van projectideeën en uitgewerkte subsidieaanvragen voor de subsidieregeling (Advenzo) - Zorginstituut

Alternate membership Veelbelovende Zorg - Adviseren over methodologie in co-creaties - ZonMW/ZIN

Member Steering Group Scientific Committee ICTRP (WHO) - Wetenschappelijke koers voor internationale trial-registratie en datatransparantie mede vormgeven - WHO

WHO Essential Diagnostic List (EDL) Evidence Submission Methodological Reviewer - Toetsen van de methodologisch de bewijsvoering voor de wereldwijde lijst van essentiële diagnostiek - WHO

Member Editorial Board Journal for Diagnostic and Prognostic Research. - Redacteurschap om de wetenschappelijke kwaliteit van publicaties te bewaken - Journal for Diagnostic and Prognostic Research

Member Council and Methods Groups (Prognosis, Screening and Diagnostic Tests) - Methodology development - Cochrane

Member WHO International Clinical Trial Registry Platform (ICTRP) Scientific Advisory Group. - Adviesrol die wereldwijd bijdraagt aan de transparantie en registratie van klinische onderzoek - WHO